Tredje AP fonden Decreases Position in Cardinal Health, Inc. (NYSE:CAH)

Tredje AP fonden trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 50.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,200 shares of the company’s stock after selling 19,199 shares during the period. Tredje AP fonden’s holdings in Cardinal Health were worth $2,271,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. State Street Corp lifted its stake in shares of Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after acquiring an additional 627,253 shares during the last quarter. Raymond James Financial Inc. purchased a new position in Cardinal Health in the 4th quarter worth approximately $45,115,000. Two Sigma Advisers LP lifted its position in Cardinal Health by 47.9% in the third quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock valued at $118,197,000 after purchasing an additional 346,362 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its stake in shares of Cardinal Health by 230.0% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company’s stock valued at $52,819,000 after purchasing an additional 333,095 shares during the period. Finally, Worldquant Millennium Advisors LLC grew its holdings in shares of Cardinal Health by 77.3% in the third quarter. Worldquant Millennium Advisors LLC now owns 593,007 shares of the company’s stock worth $65,539,000 after purchasing an additional 258,541 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Trading Down 0.5 %

Shares of Cardinal Health stock opened at $126.24 on Friday. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $132.84. The firm has a market capitalization of $30.49 billion, a P/E ratio of 23.55, a P/E/G ratio of 1.49 and a beta of 0.66. The business has a fifty day simple moving average of $125.99 and a two-hundred day simple moving average of $119.14.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.60%. Cardinal Health’s dividend payout ratio is currently 37.69%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on CAH shares. JPMorgan Chase & Co. increased their price target on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Wells Fargo & Company increased their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a research note on Tuesday, January 7th. Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $132.00 to $145.00 in a research report on Monday, January 6th. Finally, Citigroup lifted their price objective on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.